SEC Company Response from TELA Bio, (TELA) — Dec 16, 2025
TELA Bio, Inc.
Date: Dec. 16, 2025 · CIK: 0001561921 · Accession: 0001104659-25-121648
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-292090
Letter
TELA Bio, Inc.
1 Great Valley Parkway, Suite 24
Malvern, Pennsylvania 19355
December 16, 2025
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Industrial Applications and Services
100 F Street, N.E.
Washington, D.C. 20549-7553
Re: TELA Bio, Inc.
Registration Statement on Form S-3 Filed December 12, 2025 (File No. 333-292090)
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, TELA Bio, Inc. (the " Company ") hereby requests that the effective date of the Company's Registration Statement on Form S-3 (File No. 333-292090) (the " Registration Statement ") be accelerated so that the Company's Registration Statement will become effective at 4:01 P.M., Eastern Time, on December 18, 2025, or as soon thereafter as is practicable.
Please contact Justin S. Platt, Esq. of Goodwin Procter LLP, counsel to the Company, at (212) 459-7340 to provide notice of effectiveness, or if you have any questions or comments concerning this request.
[ Remainder of the page intentionally left blank ]
Very truly yours,
TELA BIO, INC.
Show Raw Text
CORRESP 1 filename1.htm TELA Bio, Inc. 1 Great Valley Parkway, Suite 24 Malvern, Pennsylvania 19355 December 16, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Industrial Applications and Services 100 F Street, N.E. Washington, D.C. 20549-7553 Re: TELA Bio, Inc. Registration Statement on Form S-3 Filed December 12, 2025 (File No. 333-292090) Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, TELA Bio, Inc. (the " Company ") hereby requests that the effective date of the Company's Registration Statement on Form S-3 (File No. 333-292090) (the " Registration Statement ") be accelerated so that the Company's Registration Statement will become effective at 4:01 P.M., Eastern Time, on December 18, 2025, or as soon thereafter as is practicable. Please contact Justin S. Platt, Esq. of Goodwin Procter LLP, counsel to the Company, at (212) 459-7340 to provide notice of effectiveness, or if you have any questions or comments concerning this request. [ Remainder of the page intentionally left blank ] Very truly yours, TELA BIO, INC. By: /s/ Antony Koblish Name: Antony Koblish Title: Chief Executive Officer